期刊文献+

流感病毒感染对慢性阻塞性肺疾病患者氧化应激和全身炎性反应的影响 被引量:7

Oxidative Stress and systemic inflammation in patients with AECOPD induced by influenza virus
下载PDF
导出
摘要 目的:研究流感病毒感染对慢性阻塞性肺疾病急性加重(AECOPD)氧化应激和炎性反应的影响。方法:选取200例可疑病毒感染的AECOPD门诊患者,用RT-PCR方法检测患者痰液中流感病毒A。流感病毒感染患者为流感组,稳定期COPD患者为对照组。比较两组患者痰液丙二醛(MDA)、超氧化物岐化酶(SOD)水平,血浆IL-6和IL-8水平。分析流感病毒表达与氧化应激指标和炎症指标的相关性。结果:流感病毒感染患者25例。流感组痰MDA水平(6.64±1.22)nmol/ml,高于对照组,而SOD水平(58.47±6.79)U/ml,低于对照组,组间差异有统计学意义(P均<0.05)。流感组血浆IL-6和IL-8水平分别为(67.89±15.8)pg/ml和(5.81±1.09)ng/ml,均高于对照组(P<0.05)。流感组内,流感病毒表达强度与痰MDA水平相关(r=0.557,P﹤0.05),而痰MDA与血浆IL-8水平正相关(r=0.463,P<0.05)。结论:流感病毒感染引起的慢性阻塞性肺疾病急性加重患者气道氧化应激状态增强和全身炎症增强。 Objective To investigate oxidative stress and system inflammation of acute exacerbation of chronic obstructive ptdmonary disease induced by influenza virus. Method Two hundreds successive out - patients with AECOPD were enrolled to detect the influenza vi- ruses A (FluA) in sputum by RT- PCR. The AECOPD with positive Flu A in sputum were divided into Group Flu, and 20 stable COPD patients were selected as control. The content of MDA and activity of SOD in sputum, as well as the IL - 6 and IL - 8 in plasma were deter- mined with different assay kits. Results A higher level.of sputum MDA and lower activity of sputum SOD were detected in group FLu than control group( P 〈 0. 05 ). The plasma IL -6 and IL -8 were increased in group FLu than control group( P 〈 0. 05 ). There are significant correlation between sputum Flu and MDA ( r = 0. 557, P 〈 0. 05 ), as well as sputum MDA and plasma IL- 8 ( r = 0. 463, P 〈 0. 05 ) . Conclusion There was remarkable deterioration in system inflammation in patients with acute exacerbation of chronic obstructive pulmona- ry disease induced by influenza virus, aeeompanylng with the serious imbalance of oxidative stress.
出处 《吉林医学》 CAS 2013年第25期5093-5095,共3页 Jilin Medical Journal
基金 山东省医药卫生科技发展计划项目[项目编号:2009H2028] 青岛市公共领域科技支撑计划项目[项目编号:10-3-3-4-3-nsh]
关键词 慢性阻塞性肺病 流感病毒 氧化应激 炎性反应 Chronic obstructive pulmonary dise^se Lufluenza virus Oxidative stress Inflammation
  • 相关文献

参考文献11

  • 1Varkey JB,Varkey B. Viral infections in patients with chro- Me obstructive pulmonary disease [ J ]. Cur Opinion Pulm Med, 2008,14(2) :89. 被引量:1
  • 2Global Strategy for the Diagnosis, Management and Preven- tion of Chronic Obstructive Lung Disease (update2010). Available from: http ://www. gnldcopd, org/ Guidelines/guideline - 2010 - gold - report, html. 被引量:1
  • 3刘凌云,曾勉,谢灿茂,高景辉,严英硕,卢桂芳,王辉,贺云鹏.慢性阻塞性肺病患者氧化应激状态及其与糖皮质激素受体水平的相关性[J].南方医科大学学报,2008,28(6):992-996. 被引量:12
  • 4Rohde G,Wiethege A,Borg I,et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case - control study [ J ]. Thorax, 2003,58 ( 1 ) : 37. 被引量:1
  • 5Gorse GJ,O'eonnor TZ,Young SL,et al. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination [ J ]. Chest,2006,130 (4) : 1109. 被引量:1
  • 6Inonu H,Doruk S,Sahin S,et al. Oxidative stress levels in exhaled breath condensate associated with COPD and smoking[J] ~ Respir Care, 2012,57 ( 3 ) :413. 被引量:1
  • 7Yamada Y, Limmon GV, Zheng D, et al. Major shifts in the spatio - temporal distribution of lung antioxidant enzymes during influenza pneumonia[J]. Plos 0ne,2012,7(2) :e31494. 被引量:1
  • 8Yatmaz S, Seow HI, Gualano RC, et al. Glutathione Peroxi- dase - 1 ( GPx - 1 ) reduces influenza A virus - induced lung in- flammation, 2012. 被引量:1
  • 9Mata M, Morcillo E, Gimeno C, et al. N - acetyl - L - cyste- ine (NAC) inhibit mucin synthesis and pro- inflammatory media- tots in alveolar type Ⅱ epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV) [J]. Biochem Pharmacol, 2011,82 (5) : 548. 被引量:1
  • 10Yageta Y, Ishii Y, Morishima Y ,et al. Role of Nrf2 in host defense against influenza virus in cigarette smoke - exposed mice [J]. J Virol,2011,85(10) :4679. 被引量:1

二级参考文献22

  • 1曾勉,吴健锋,谢灿茂,严英硕,陈冬梅,禤建美.慢性阻塞性肺疾病急性加重期患者规范化痰诱导安全性的初步研究[J].中华结核和呼吸杂志,2005,28(4):238-241. 被引量:45
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3Rabe KF,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmoary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):532. 被引量:1
  • 4Celli BR,MacNee W.Standards for the diagnosis and treatment of COPD[J].Eur Respir J,2004,23(4):932. 被引量:1
  • 5American Thoracic Society.Standards for the diagnosis and case of patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,1995,152(1):78. 被引量:1
  • 6O′Donnell D,Lam M,Webb K.Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,1999,160(3):542. 被引量:1
  • 7Van Noord J,Aumann J,Jasnseens E,et al.Comparison of tiotropium qd,formoterol bid and both combined qd in patients with COPD[J].Eur Respir J,2005,26(2):214. 被引量:1
  • 8Barnes PJ,Ito K,Adcock IM.Corticosteroid resistance in chronic obstructive pulmonary disease:inactivation of histone deacetylase[J].Lancet,2004,363(3):731. 被引量:1
  • 9Friedman M,Serby C,Menjoge S,et al.Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD[J].Chest,1999,115(3):635. 被引量:1
  • 10Soares SM,Oliveira RA,Franca SA,et al.Continuous positive airway pressure increases inspiratory capacity of COPD patients[J].Respirology,2008,13(2):387. 被引量:1

共引文献17

同被引文献85

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部